News

News

TSO3 Provides Duodenoscope Regulatory Filing Update

Quebec City, Canada and Myrtle Beach, United States, December 19, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has had further dialogue with US Regulators in connection with their recent request for additional information (AI) regarding the Company’s submission to extend claims of its STERIZONE® VP4 Sterilizer to include terminal sterilization of duodenoscopes.

Read more

News

TSO3 Provides Duodenoscope Regulatory Filing Update

Quebec City, Canada and Myrtle Beach, United States, December 19, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has had further dialogue with US Regulators in connection with their recent request for additional information (AI) regarding the Company’s submission to extend claims of its STERIZONE® VP4 Sterilizer to include terminal sterilization of duodenoscopes.

Read more

News

TSO3 Announces the Death of Mr. Jean Lamarre

Quebec City, Canada and Myrtle Beach, United States, November 27, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, sadly announced the death of Mr. Jean Lamarre, a member of the Board of Directors of TSO3. Mr. Lamarre contributed sound and constructive counsel on TSO3’s Board of Directors, and while leading TSO3’s Human Resources Committee. Mr. Lamarre was a pillar of the Canadian business community, holding several board positions, including the position of Board Chair for SEMAFO, and various other positions of significant responsibility with Groupe Lavalin and numerous other organizations.

Read more

News

TSO3 Reports Record Third Quarter 2017 Results

Quebec City, Canada and Myrtle Beach, United States, November 6, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for its third fiscal quarter 2017 ended September 30, 2017.

Read more

News

TSO3 Sets Third Quarter Earnings Call for Tuesday, November 7, 2017 at 8:30 a.m. EST

Québec City, Canada and Myrtle Beach, United States of America, October 25, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Tuesday, November 7, 2017, to discuss its financial results for the third quarter ended September 30, 2017. Financial results will be issued in a press release prior to the call.

Read more